I'm more than happy to wait for the assay results. Don't see the need to announce visual on cores because it can deflate any potential run on assay results as it is then expected. The way I see it, NKL's share price has dropped to a point where there is practically no expectation of positive results. So if there is any hint of sulphides in this drill campaign...well you know the rest
IMHO there has never been a better time to buy NKL shares
- Forums
- ASX - By Stock
- NKL interview with “The Pick”
I'm more than happy to wait for the assay results. Don't see the...
Featured News
Add NKL (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.581M |
Open | High | Low | Value | Volume |
1.8¢ | 1.8¢ | 1.8¢ | $2.805K | 155.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 74191 | 1.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.0¢ | 22727 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 74191 | 0.018 |
2 | 525000 | 0.017 |
1 | 187562 | 0.016 |
1 | 100000 | 0.015 |
1 | 36000 | 0.014 |
Price($) | Vol. | No. |
---|---|---|
0.020 | 22727 | 1 |
0.025 | 10000 | 1 |
0.028 | 53756 | 1 |
0.029 | 5000 | 1 |
0.030 | 82416 | 1 |
Last trade - 15.38pm 06/05/2024 (20 minute delay) ? |
Featured News
NKL (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online